Medsec made the news in August when they released information on vulnerabilities in St. Jude's pacemaker products that could endanger human lives. The release of a vulnerability is not new. What makes this novel and controversial is Medsec is working with the investment firm Muddy Waters who is shorting the St. Jude stock. Dale Peterson will interview Medsec CEO Justine Bone on the S4 Main Stage.